Stavros Rafail
About Stavros Rafail
Stavros Rafail is a Principal Scientist at Adaptimmune, specializing in immunology with over 12 years of experience in developing immunotherapies. He has a strong academic background, holding a Doctorate in Immunology/Coagulation and a B.Sci. in Biology, and has held various research roles at prestigious institutions including the Perelman School of Medicine at the University of Pennsylvania.
Current Role at Adaptimmune
Stavros Rafail serves as a Principal Scientist at Adaptimmune, a position he has held since 2019. In this role, he provides clinical and scientific input during the development and implementation of clinical trials. He collaborates closely with various teams, including Translational Medicine, Business Development, CMC, Research, and Commercialization, to facilitate the execution of three clinical trials. His work involves the preparation and submission of clinical portions of all relevant regulatory filings.
Previous Experience at Adaptimmune
Prior to his current role, Stavros Rafail worked at Adaptimmune as a Senior Scientist from 2017 to 2019. During this time, he contributed to the identification of novel therapeutic biomarkers and targets in cancer. His experience at Adaptimmune laid the groundwork for his current responsibilities and expertise in clinical trial development.
Educational Background
Stavros Rafail holds a Bachelor of Science in Biology from the University of Bath, where he studied from 1997 to 2000. He furthered his education with a Doctorate in Immunology/Coagulation from Dimokrition Panepistimion Thrakis, completing his studies from 2003 to 2007. Additionally, he earned a Master of Business Administration from the University of Liverpool in 2001 and a Master of Medical Science in Assisted Reproduction Technology from the University of Nottingham in 2002.
Research Experience at Perelman School of Medicine
Stavros Rafail has extensive research experience at the Perelman School of Medicine at the University of Pennsylvania. He served as a Postdoctoral Researcher from 2008 to 2013, followed by a role as a Senior Research Investigator from 2016 to 2017. His work in this institution focused on various aspects of immunology, contributing to his expertise in developing immunotherapies.
Expertise in Immunology
With over 12 years of experience in immunology, Stavros Rafail specializes in developing immunotherapies, including DNA and dendritic cell vaccines and adoptive cell transfer. He possesses expertise in executing and managing high throughput assays, multicolor flow cytometry, primary cell culture, protein purification, and molecular cloning, which are essential skills in his current scientific role.